Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics
Gritstone Oncology, Inc. (GRTS)
Today's Latest Price: $10.50 USD
0.29 (-2.69%)
Updated Jan 22 1:08pm
Add GRTS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GRTS Stock Summary
- GRTS's went public 1.32 years ago, making it older than just 1.14% of listed US stocks we're tracking.
- With a price/sales ratio of 88.5, Gritstone Oncology Inc has a higher such ratio than 97.56% of stocks in our set.
- Gritstone Oncology Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -40.2%, greater than the shareholder yield of merely 7.97% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Gritstone Oncology Inc are ALPN, VCNX, PTI, UMRX, and ARDS.
- Visit GRTS's SEC page to see the company's official filings. To visit the company's web site, go to www.gritstoneoncology.com.
GRTS Daily Price Range
GRTS 52-Week Price Range
GRTS Stock Price Chart More Charts
GRTS Price/Volume Stats
| Current price | $10.50 | 52-week high | $16.04 |
| Prev. close | $10.79 | 52-week low | $7.00 |
| Day low | $10.25 | Volume | 90,164 |
| Day high | $11.49 | Avg. volume | 216,060 |
| 50-day MA | $8.74 | Dividend yield | N/A |
| 200-day MA | $9.79 | Market Cap | 375.96M |
Gritstone Oncology, Inc. (GRTS) Company Bio
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.
Top Stories View All
Will Aphria’s (APHA) New European Certification Propel the Stock Higher?
Best & Worst Performing Stock Industries for January 21, 2020
Best & Worst Performing Small Cap Stocks for January 21, 2020
Best & Worst Performing Mid Cap Stocks for January 21, 2020
Best & Worst Performing Large Cap Stocks for January 21, 2020
View All Top Stories
Loading social stream, please wait...